Navigation Links
President of the Florida Osteopathic Medical Association Joins With Retasure™ to Prevent Vision Loss
Date:3/22/2009

Philip L. Shettle, D.O., has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. Shettle is a board certified Fellow of the American Osteopathic College of Ophthalmology and an Osteopathic Fellow of the American Academy of Ophthalmology. He is a practicing General Ophthalmologist in Largo, Florida.

(PRWEB) March 22, 2009 -- Philip L. Shettle, D.O., has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. Shettle is a board certified Fellow of the American Osteopathic College of Ophthalmology and an Osteopathic Fellow of the American Academy of Ophthalmology. He is a practicing General Ophthalmologist in Largo, Florida.

The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Certified readers, like Dr. Shettle, use the ophthalmic specific review tools in Retasure™ to assess the images and consult with the primary care physician.

"The incidence of Diabetic Eye Disease in our population is growing exponentially. Early diagnosis and treatment of diabetic retinopathy will prevent vision loss in our patients and will allow them to lead productive and independent lives. Examination of the retina is key to preventing vision loss due to diabetic retinopathy. The most important health care priority is the delivery of quality medical care. Retasure will help you help your patients," states Dr. Shettle.

Scott Sanner, Vice President of North American Operations for Digital Healthcare, agrees. "The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."

Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinology physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups. More than a million patients around the world have received a retinal health assessment using Digital Healthcare software.

For additional information, please visit www.retasure.com

CONTACT: Scott Sanner (866) 539-4213

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2252934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. HIPAA Amendments Contained in President Obamas Stimulus Bill Among New Sessions Added to HCCAs 2009 Compliance Institute
2. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
3. President of the Mississippi Eye, Ear, Nose and Throat Society Joins with Retasure to Prevent Vision Loss
4. American Association for Homecare Applauds President Obamas Plan to Aid Small Businesses
5. Wendy E. Roberts, MD, Named 2009-2010 President of the Womens Dermatologic Society
6. VVA Praises Presidents Budget Submission for Veterans Affairs; Condemns Ill-advised Revenue Proposal
7. Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
8. The American Legion Strongly Opposed to Presidents Plan to Charge Wounded Heroes for Treatment
9. The Danger of President Obamas Insurance for Children (SCHIP)
10. Grocery Manufacturers Association Statement Regarding President Obamas Nomination of FDA Commissioner
11. Appointment of Margaret Hamburg to Lead FDA Lauded by Gov. Lowell Weicker, President of the Board of Trust for Americas Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... NC (PRWEB) , ... January 18, 2017 , ... The ... remain on Team V, its official endurance training and fundraising team, to compete in ... V Foundation welcomes those inspired to finish the world’s oldest annual marathon to join ...
(Date:1/18/2017)... ... January 18, 2017 , ... Park Agencies ... planning services to families and business owners in the greater Kansas City area, ... with developmental disabilities. , The Lakemary Center is a comprehensive educational resource center ...
(Date:1/18/2017)... ... 2017 , ... Michael J. Hennessy Associates, Inc., (MJH), a ... Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael J. Hennessy, Jr. The ... thought leader interaction in, live video and interactive digital platforms. , In making ...
(Date:1/18/2017)... ... , ... Floundering on New Year’s resolutions? Need an excuse to get back ... The U.S. Apple Association agrees and recommends starting each day with apples, a ... heart disease. , The U.S. Apple Association – which represents apple growers and producers ...
(Date:1/17/2017)... California (PRWEB) , ... January 17, 2017 , ... ... have a point of difference. Eden Activewear is a stand-out company for several ... are exclusively online and only manufacture on demand, this is called 'Agile' manufacturing ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 17, 2017 Research and Markets has ... 2017 - 2024" report to their offering. ... This new report revisits the ... that was issued in May of 2015. Self-healing is an area ... previous analysis we projected a market potential of $2.7 billion ($US) ...
(Date:1/17/2017)... -- Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity ... a variety of National Institute of Allergy ... activities. The IDIQ mechanism will allow Paragon to ... awards up to $159 million. Paragon ... development of biopharmaceuticals, is one of four awardees ...
(Date:1/17/2017)... Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA ... Q1 2017   ... Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical company, ... rd at 8:30am Eastern Time to discuss the recent acquisition of a ...
Breaking Medicine Technology: